Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 36977

Brownsburg, IN 46112


Study Summary:

A phase IV, randomized, multi-center, open-label study to evaluate patient preference of Movantik versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) treatment. Study will last a total of 7 weeks and require 5 office visits.


Qualified Participants Must:

• Be between 18 and 84 years of age
• Have constipation caused by pain medication. (OIC)
• Be currently using pain medication for 1 month or longer and experiencing chronic constiption


Qualified Participants May Receive:

Open label OIC medication, study related exams and compensation at every visit


Research Site Profile

View Clinic Profile